NKMAX has developed the world ‘s first and only commercially available NK Cell activity test. In addition, NKMAX provides high quality health supplements to help strengthen the immune system.
NKMAX recently expanded its business to the cell therapy market by focusing on the immune system and developing an immunotherapy called SuperNK, which overcomes the limitations of existing NK cell therapy. NKMAX aims to provide the safest and most effective immunotherapy.
NKMAX
Category:
Venture
Main Business Area
Specialized biological research reagents for the biotech and health industries
NKMAX’s proteins and antibodies development has stemmed from its stable-peptide (SP) fusion technology, which was originally designed to stabilize proteins susceptible to damage from its environment.
NKMAX manufactures more than 5,000 different recombinant proteins and over 400 monoclonal antibodies being sold in over 38 countries around the world.
| Contact Details | 1F/6F, SNUH Healthcare Innovation Park, 172, Dolma-ro, Bundang-gu, Seongnam-si, Gyeonggi-do +82-31-8017-8114info@nkmax.com |
|---|
Find out more companies
Related products
-
VentureMedigen Human Care
T cell immunotherapies for solid tumors, vaccine safety and natural immunity
-
-
-
-
